sur EBD Group
Biotech Showcase™ 2026: A Hub for Global Biopharma Leaders
Biotech Showcase™ 2026 is set to return to San Francisco during J.P. Morgan Healthcare Week from January 12-14, with a virtual component on January 21-22. The event continues its 19-year tradition as a pivotal meeting point for over 3,200 global biopharmaceutical professionals and 1,200 life sciences investors. Participants include companies such as PhRMA, BIO, Novo, Ipsen, Regeneron, and Sofinnova Investments.
Attendees will have the opportunity to engage in one-to-one meetings, corporate presentations, and networking sessions. The event also integrates with the TechBio and Seed Showcases, offering a broad spectrum of life science innovations. Virtual attendees will have access to company showcases and session recordings.
The 2026 agenda focuses on industry trends including AI in healthcare, biopharma financing, and the future of healthcare access and equity. A projected 6,000+ one-to-one meetings highlight the event's role in facilitating deal-making and industry growth.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de EBD Group